tetradecanoylphorbol acetate has been researched along with carvedilol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feuerstein, G; McKenna, PJ; Ruffolo, RR; Yue, TL | 1 |
| Cheng, HY; Feuerstein, GZ; Gu, JL; McKenna, PJ; Ruffolo, RE; Yue, TL | 1 |
| Arleth, AJ; Eichman, C; Ohlstein, EH; Sung, CP; Truneh, A | 1 |
| Domoto, K; Ishikawa, Y; Kawasaki, S; Okuda, M; Taguchi, M; Takahashi, A; Takahashi, T; Taniguchi, T; Yokoyama, M | 1 |
| Danihelová, E; Jancinová, V; Májeková, M; Nosál, R; Petríková, M | 1 |
| Fyhrquist, F; Nyman, T; Saijonmaa, O | 1 |
| Drábiková, K; Holománová, D; Jancinová, V; Murín, J; Nosál', R; Solík, P | 1 |
| Cupanikova, D; Lojek, A; Macickova, T; Nosal, R; Pecivova, J; Pekarova, M | 1 |
1 trial(s) available for tetradecanoylphorbol acetate and carvedilol
| Article | Year |
|---|---|
On the antioxidant activity of carvedilol in human polymorphonuclear leukocytes in vitro and ex vivo.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Antioxidants; Carbazoles; Carvedilol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Heart Failure; Humans; In Vitro Techniques; Luminescence; Luminol; Male; Middle Aged; Neutrophils; Propanolamines; Reactive Oxygen Species; Tetradecanoylphorbol Acetate | 2006 |
7 other study(ies) available for tetradecanoylphorbol acetate and carvedilol
| Article | Year |
|---|---|
Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Carbazoles; Carvedilol; Free Radical Scavengers; Fumarates; Humans; In Vitro Techniques; Lipid Peroxidation; Neutrophils; Propanolamines; Superoxides; Tetradecanoylphorbol Acetate; Vasodilator Agents | 1992 |
Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Carbazoles; Carvedilol; Cattle; Cells, Cultured; Electron Spin Resonance Spectroscopy; Endothelium, Vascular; Humans; L-Lactate Dehydrogenase; Neutrophils; Propanolamines; Pulmonary Artery; Reactive Oxygen Species; Tetradecanoylphorbol Acetate; Vasodilator Agents; Xanthine; Xanthine Oxidase; Xanthines | 1994 |
Carvedilol, a multiple-action neurohumoral antagonist, inhibits mitogen-activated protein kinase and cell cycle progression in vascular smooth muscle cells.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Carvedilol; Cell Cycle; Cells, Cultured; Enzyme Inhibitors; Humans; Male; Muscle, Smooth, Vascular; Phosphorylation; Platelet-Derived Growth Factor; Propanolamines; Rats; Rats, Sprague-Dawley; Tetradecanoylphorbol Acetate; Thymidine Kinase | 1997 |
Participation of reactive oxygen intermediates in the angiotensin II-activated signaling pathways in vascular smooth muscle cells.
Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Aorta, Thoracic; Carbazoles; Carvedilol; Cells, Cultured; Epidermal Growth Factor; Hydrogen Peroxide; Muscle, Smooth, Vascular; Propanolamines; Rats; Reactive Oxygen Species; Signal Transduction; Tetradecanoylphorbol Acetate | 2000 |
Antiplatelet activity of carvedilol in comparison to propranolol.
Topics: Adenosine Diphosphate; Calcimycin; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Propanolamines; Propranolol; Reference Values; Tetradecanoylphorbol Acetate | 2002 |
Carvedilol inhibits basal and stimulated ACE production in human endothelial cells.
Topics: Carbazoles; Cardiovascular Agents; Carvedilol; Cells, Cultured; Endothelium, Vascular; Humans; Immunoblotting; Peptidyl-Dipeptidase A; Phosphorylation; Propanolamines; Protein Kinase C; RNA, Messenger; Tetradecanoylphorbol Acetate; Umbilical Veins; Vascular Endothelial Growth Factor A; Vasodilator Agents | 2004 |
Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils.
Topics: Adrenergic beta-Antagonists; Androstadienes; Calcimycin; Carbazoles; Carvedilol; Humans; In Vitro Techniques; Male; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oxidants; Peroxidase; Phosphatidylinositol 3-Kinases; Propanolamines; Protein Kinase C; Receptors, Adrenergic, beta; Stimulation, Chemical; Superoxides; Tetradecanoylphorbol Acetate; Wortmannin | 2008 |